Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis. Martin R, Sospedra M, Rosito M, Engelhardt B Eur J Immunol. 2016 Jul 28. PMID: 27467894. Abstract CommentRecommendBookmarkWatch